查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824171

益生菌市场：2025-2030 年预测

Probiotics Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

益生菌市场规模：

益生菌市场预计将从 2025 年的 985.85 亿美元成长到 2030 年的 1,705.07 亿美元，复合年增长率为 11.58%。

益生菌市场涵盖活菌和酵母，它们对人类和动物的健康有益，特别有助于改善消化器官系统。这些有益微生物能够增强免疫系统，减少肠道炎症，改善肠道健康，防止蛋白质和脂质的氧化分解，同时减少体内致病菌。

基于市场和健康应用

益生菌在多种健康状况中展现出治疗潜力，其应用范围已从传统的消化器官系统扩展到心理健康和神经系统疾病的管理。肠脑关係研究支持益生菌在治疗心理健康问题的应用。据医学权威机构称，近年来，全球范围内心理健康问题的发病率显着上升。

该技术不断扩展的治疗范围包括支持各种神经系统疾病的诊断和治疗，这意味着益生菌的应用领域正在不断扩大，其效用已超越传统的消化器官系统健康益处。这种市场多元化正在创造新的市场机会，同时也支持更广泛的医疗保健应用。

市场成长的关键驱动力

消费者日益增强的健康意识是推动市场扩张的一个根本因素，他们积极寻求健康食品作为日常消费。人们对饮食与健康关係的理解日益加深，推动了对富含益生菌的食品、饮料和膳食补充剂的需求，这些产品既能提供基本的营养，又能促进健康。

人口结构变化，包括人口老化，尤其是在新兴经济体，正在创造对健康保健产品的持续需求。可支配收入水准的提高和生活方式的改变推动了高级产品的普及，而食品消费模式的改变则推动益生菌被纳入日常饮食中。

全球年轻人健身和健康的趋势正在推动营养补充剂行业的显着增长。注重健康的消费者越来越多地将益生菌纳入健身计划和整体健康策略中，从而为特殊配方创造了持续的市场需求。

产品创新扩展到巧克力、饼干、饮料和食品等不同类别，正在扩大市场准入和消费者接受度。这些创新提供了多种消费选择，以满足不同的偏好和生活方式需求。

市场区隔与分布

由于加工食品消费量不断增长、不良生活方式选择以及卫生部门和媒体不断加强的营养教育，机能性食品和饮料领域有望保持显着的市场份额。这类产品既有益健康，也易于融入现有的饮食习惯。

由于饮食模式的改变导致肉类消费增加，尤其是在新兴经济体，动物饲料应用显示出巨大的成长潜力。益生菌在畜牧生产可确保动物健康，同时应对疾病爆发问题，并提高肉类和生产效率。

受健身和健康意识的推动，尤其是年轻一代，营养补充剂行业正在经历显着增长。针对特定健康目的的益生菌菌株的先进研发，进一步加速了该领域的市场扩张。

区域市场分析

由于印度和中国等新兴经济体的需求不断增长，亚太地区拥有巨大的成长潜力。人口快速增长、可支配收入不断提高以及人们对健康益处的认识不断增强，推动市场扩张。养乐多等新兴市场品牌正成功渗透到该地区市场，推动整个品类的发展。

北美地区製造商在化妆品和医药应用领域投入巨资，带来了巨大的成长机会。该地区先进的科研基础设施和注重健康的消费者支持高级产品的采用和创新发展。

菌株类型及成分分析

乳酸桿菌和双歧桿菌是全球食品和饲料领域最常使用的非芽孢益生菌。这些菌株已证实在乳製品中有效，可提高乳糖耐受性和抗致病菌能力，同时支持整体肠道健康。

细菌部分占据主导市场份额，因为它具有广泛的健康益处，例如增加乳糖酶的产生、预防腹泻、预防免疫系统疾病、增强乳酸桿菌免疫力等。其他微生物包括酿酒酵母、大肠桿菌和肠球菌，可提供专门的应用。

市场限制和投资挑战

高昂的研发成本是市场进入和产品开发的一大障碍。建立实验室、购买研究设备以及招募训练有素的专业人员都需要大量的初始投资，而且由于益生菌产品与健康密切相关，其回报可能无法立即显现。

科汉森、达能、养乐多和雀巢等现有市场参与者已实施了全面的研发策略，为新参与企业设置了竞争壁垒。益生菌菌株开发和测试的资本密集性质限制了参与企业市场。

竞争格局与策略发展

主要市场参与企业包括养乐多本社株式会社、达能公司、雀巢公司、Probi AB、Lifeway Foods、BioGaia、Mother Dairy Fruit and Vegetable Pvt. Ltd.、Arla Foods AMBA、i-Health, Inc. 和 Chr. Hansen Holding A/S。这些公司正在实施多元化成长策略，包括产品开发、策略伙伴关係和市场扩张倡议。

战略产业影响

对于营养补充剂行业的专业人士来说，益生菌市场代表着机能性食品、膳食补充剂和治疗用途交汇的机会。成功的关键在于平衡创新投资与市场准入，同时满足消费者在食品、补充剂和特殊健康应用领域的多样化需求。

市场向心理健康应用和先进菌株开发方向发展，为开发针对特定健康状况的益生菌解决方案的公司提供了机会，同时透过易于获取的产品形式保持广泛的消费者吸引力。

本报告的主要优点

  • 深刻分析：获得涵盖主要地区和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业所采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力来制定策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具成本效益的。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 实际数据为2022年至2024年，预测数据为2025年至2030年
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（策略、产品、财务、主要发展等）

目录

第一章执行摘要

第二章市场概述

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章 益生菌市场（依成分）

  • 介绍
  • 细菌
  • 酵母菌

6. 益生菌市场（按功能）

  • 介绍
  • 常规的
  • 预防保健
  • 治疗

7. 益生菌市场类型

  • 介绍
  • 乳酸菌
  • 链球菌
  • 双歧桿菌
  • 孢子形成者
  • 其他的

第八章益生菌市场（按应用）

  • 介绍
  • 机能性食品和饮料
  • 营养补充品
  • 动物饲料

9. 益生菌市场（按最终用户）

  • 介绍
  • 人类益生菌
  • 动物益生菌

第 10 章益生菌市场（按地区）

  • 介绍
  • 北美洲
    • 按材质
    • 按功能
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按材质
    • 按功能
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按材质
    • 按功能
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 按材质
    • 按功能
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 按材质
    • 按功能
    • 按类型
    • 按用途
    • 按最终用户
    • 按国家
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第十一章竞争格局及分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十二章：公司简介

  • Yakult Honsha Co., Ltd.
  • Danone SA
  • Nestle SA
  • Probi AB
  • Lifeway Foods
  • BioGaia
  • Mother Dairy Fruit and Vegetable Pvt. Ltd.
  • Arla Foods AMBA
  • i-Health, Inc.,
  • Chr. Hansen Holding A/S

第十三章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061610449

Probiotics Market Size:

The Probiotics Market is expected to grow from USD 98.585 billion in 2025 to USD 170.507 billion in 2030, at a CAGR of 11.58%.

The probiotics market encompasses live bacteria and yeasts that provide health benefits to humans and animals, particularly through digestive system improvement. These beneficial microorganisms strengthen immune systems, reduce intestinal inflammation, improve gut health, and protect against oxidative destruction of proteins and lipids while reducing pathogenic organisms in the body.

Market Foundation and Health Applications

Probiotics demonstrate therapeutic potential across multiple health conditions, extending beyond traditional digestive applications into mental health and neurological disorder management. The gut-brain connection research supports probiotic applications in addressing mental health conditions, which have experienced significant global prevalence increases over recent years according to health organizations.

The technology's expanding therapeutic scope includes diagnosis and treatment support for various neurological disorders, representing a growing application area that extends probiotic utility beyond conventional digestive health benefits. This diversification creates new market opportunities while supporting broader healthcare applications.

Primary Market Growth Drivers

Increasing health awareness represents the fundamental driver of market expansion, as consumers actively seek healthy food products for daily consumption. The growing understanding of diet-health relationships drives demand for probiotic-enhanced foods, beverages, and dietary supplements that provide both basic nutrition and health enhancement benefits.

Demographic changes including aging populations, particularly in developing economies, create sustained demand for health-supporting products. Rising disposable income levels and lifestyle changes support premium product adoption, while changing food consumption patterns drive probiotic integration into daily dietary routines.

The fitness and wellness trend among younger global populations drives notable growth in the dietary supplements segment. Health-conscious consumers increasingly incorporate probiotics into fitness regimens and general wellness strategies, creating sustained market demand for specialized formulations.

Product innovation expansion into diverse categories including chocolates, biscuits, beverages, and various food products broadens market accessibility and consumer adoption opportunities. These innovations provide multiple consumption options that cater to different preferences and lifestyle requirements.

Application Segmentation and Market Distribution

The functional food and beverages segment maintains significant market share through rising processed food consumption, poor lifestyle patterns, and increased nutritional education from health authorities and media. This segment benefits from convenient integration into existing dietary habits while providing health benefits.

Animal feed applications demonstrate substantial growth potential driven by changing dietary patterns leading to increased meat consumption, especially in developing economies. Probiotics in animal husbandry ensure proper animal health while addressing disease outbreak concerns, supporting meat quality and production efficiency.

The dietary supplements segment experiences notable growth through fitness awareness and health consciousness, particularly among younger demographics. Advanced probiotic strain development for specific health purposes further accelerates market expansion in this segment.

Geographic Market Analysis

The Asia Pacific region demonstrates significant growth potential through increasing demand from developing countries including India and China. Rapidly expanding populations, rising disposable income, and growing health benefit awareness drive market expansion. Established brands like Yakult successfully penetrate regional markets, supporting overall category development.

North America represents substantial growth opportunities through significant manufacturer investments in cosmetic and pharmaceutical industry applications. The region's advanced research infrastructure and consumer health awareness support premium product adoption and innovation development.

Strain Types and Ingredient Analysis

Lactobacillus and Bifidobacterium represent the most commonly used non-spore-forming probiotics in food and feed applications globally. These strains demonstrate proven efficacy in dairy products, improving lactose tolerance and pathogenic bacteria resistance while supporting overall gut health.

The bacteria segment maintains dominant market share through extensive health benefits including increased lactase production, diarrhea prevention, immune system disorder prevention, and enhanced Lactobacilli immunity. Additional microorganisms including Saccharomyces cerevisiae, Escherichia coli, and Enterococci provide specialized applications.

Market Constraints and Investment Challenges

High research and development costs present significant barriers to market entry and product development. Laboratory development, research equipment procurement, and trained professional recruitment require substantial initial investments that may not generate immediate returns due to the health-focused nature of probiotic products.

Established market players including Chr. Hansen, Danone, Yakult, and Nestle have implemented comprehensive R&D strategies that create competitive barriers for new entrants. The capital-intensive nature of probiotic strain development and testing limits market participation to well-funded organizations.

Competitive Landscape and Strategic Developments

Major market participants include Yakult Honsha Co., Ltd., Danone S.A., Nestle S.A., Probi AB, Lifeway Foods, BioGaia, Mother Dairy Fruit and Vegetable Pvt. Ltd., Arla Foods AMBA, i-Health, Inc., and Chr. Hansen Holding A/S. These companies implement diverse growth strategies including product development, strategic partnerships, and market expansion initiatives.

Strategic Industry Implications

For nutraceutical industry professionals, the probiotics market represents opportunities at the intersection of functional foods, dietary supplements, and therapeutic applications. Success requires balancing innovation investment with market accessibility while addressing diverse consumer needs across food, supplement, and specialized health applications.

Market evolution toward mental health applications and advanced strain development suggests opportunities for companies developing targeted probiotic solutions that address specific health conditions while maintaining broad consumer appeal through accessible product formats.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Probiotics Market Segmentation:

By Ingredients

  • Bacteria
  • Yeast

By Function

  • Regular
  • Preventive Healthcare
  • Therapeutic

By Type

  • Lactobacillus
  • Streptococcus
  • Bifidobacterium
  • Spore Formers
  • Others

By Application

  • Functional food and beverages
  • Dietary supplements
  • Animal Feed

By End-User

  • Human Probiotics
  • Animal Probiotics

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PROBIOTICS MARKET BY INGREDIENTS

  • 5.1. Introduction
  • 5.2. Bacteria
  • 5.3. Yeast

6. PROBIOTICS MARKET BY FUNCTION

  • 6.1. Introduction
  • 6.2. Regular
  • 6.3. Preventive Healthcare
  • 6.4. Therapeutic

7. PROBIOTICS MARKET BY TYPE

  • 7.1. Introduction
  • 7.2. Lactobacillus
  • 7.3. Streptococcus
  • 7.4. Bifidobacterium
  • 7.5. Spore Formers
  • 7.6. Others

8. PROBIOTICS MARKET BY APPLICATION

  • 8.1. Introduction
  • 8.2. Functional food and beverages
  • 8.3. Dietary supplements
  • 8.4. Animal Feed

9. PROBIOTICS MARKET BY END-USER

  • 9.1. Introduction
  • 9.2. Human Probiotics
  • 9.3. Animal Probiotics

10. PROBIOTICS MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. By Ingredients
    • 10.2.2. By Function
    • 10.2.3. By Type
    • 10.2.4. By Application
    • 10.2.5. By End-User
    • 10.2.6. By Country
      • 10.2.6.1. USA
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. By Ingredients
    • 10.3.2. By Function
    • 10.3.3. By Type
    • 10.3.4. By Application
    • 10.3.5. By End-User
    • 10.3.6. By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Others
  • 10.4. Europe
    • 10.4.1. By Ingredients
    • 10.4.2. By Function
    • 10.4.3. By Type
    • 10.4.4. By Application
    • 10.4.5. By End-User
    • 10.4.6. By Country
      • 10.4.6.1. United Kingdom
      • 10.4.6.2. Germany
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Others
  • 10.5. Middle East and Africa
    • 10.5.1. By Ingredients
    • 10.5.2. By Function
    • 10.5.3. By Type
    • 10.5.4. By Application
    • 10.5.5. By End-User
    • 10.5.6. By Country
      • 10.5.6.1. Saudi Arabia
      • 10.5.6.2. UAE
      • 10.5.6.3. Others
  • 10.6. Asia Pacific
    • 10.6.1. By Ingredients
    • 10.6.2. By Function
    • 10.6.3. By Type
    • 10.6.4. By Application
    • 10.6.5. By End-User
    • 10.6.6. By Country
      • 10.6.6.1. China
      • 10.6.6.2. Japan
      • 10.6.6.3. India
      • 10.6.6.4. South Korea
      • 10.6.6.5. Taiwan
      • 10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. Yakult Honsha Co., Ltd.
  • 12.2. Danone S.A
  • 12.3. Nestle S.A
  • 12.4. Probi AB
  • 12.5. Lifeway Foods
  • 12.6. BioGaia
  • 12.7. Mother Dairy Fruit and Vegetable Pvt. Ltd.
  • 12.8. Arla Foods AMBA
  • 12.9. i-Health, Inc.,
  • 12.10. Chr. Hansen Holding A/S

13. APPENDIX

  • 13.1. Currency
  • 13.2. Assumptions
  • 13.3. Base and Forecast Years Timeline
  • 13.4. Key benefits for the stakeholders
  • 13.5. Research Methodology
  • 13.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES